Roug, Anne S.Larsen, Hanne O.Nederby, LineJust, TomBrown, GordonNyvold, Charlotte G.Ommen, Hans B.Hokland, Peter2018-10-172018-10-172014-01-01Roug, A S, Larsen, H O, Nederby, L, Just, T, Brown, G, Nyvold, C G, Ommen, H B & Hokland, P 2014, 'HMICL and CD123 in combination with a CD45/CD34/CD117 backbone : a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia', British Journal of Haematology, vol. 164, no. 2, pp. 212-222. https://doi.org/10.1111/bjh.126140007-1048http://hdl.handle.net/2164/11285The work was supported by grants to PH from The Danish Cancer Society, The Danish MRC, The John and Birthe Meyer Foundation, and the Karen Elise Jensen Foundation. GB has received funding from The Wellcome Trust. We thank our patients for contributing samples, and for continuous input during these efforts.11523603engSDG 3 - Good Health and Well-beingAcute myeloid leukaemiaFlow cytometryLeukaemia-associated immunophenotypeMinimal residual diseaseQuantitative polymerase chain reactionR Medicine (General)HematologyWellcome TrustR1Journal article10.1111/bjh.12614http://www.scopus.com/inward/record.url?scp=84891624172&partnerID=8YFLogxK1642